wada semaglutide just added tirzepatide (mounjaro) to the 2026 Monitoring Program Does Serena Williams Take GLP-1?

The global weight loss market is projected to surpass $400 billion by 2030, with a sharp rise in demand for physician-supervised programs and prescription-based treatments

The agency does not evaluate every compounded product for safety, effectiveness or manufacturing quality before it reaches patients

Food and Drug Administration, Understanding Investigational Drugs , April 2, 2019 GoodRx, Retatrutide for Weight Loss: Availability, Dosage, and More , June 25, 2026 Food and Drug Administration, Expanded Access, accessed June 29, 2026 Eli Lilly, Expanded Access | Compassionate Use | Clinical Trials , accessed June 29, 2026 WBUR | Here & Now, An extraordinary new obesity drug is still awaiting FDA approval

Over-the-counter (OTC) options, such asdimenhydrinate (Dramamine), and prescription medications , such as ondansetron (Zofran) and metoclopramide (Reglan), may be useful